NCT02115295
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive. Study availability and eligibility vary by location and protocol.
NCT02115295
NCT03630991
NCT05857969
NCT04188405
NCT01231412
NCT04681105
NCT02311998
NCT03860376